• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ELI LILLY AND COMPANY HUMAPEN LUXURA BURGUNDY; FOR TREATMENT PURPOSES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ELI LILLY AND COMPANY HUMAPEN LUXURA BURGUNDY; FOR TREATMENT PURPOSES Back to Search Results
Model Number MS9662
Device Problem Insufficient Information (3190)
Patient Problems Hyperglycemia (1905); Loss of consciousness (2418)
Event Date 01/31/2010
Event Type  Injury  
Event Description
Lilly case id: (b)(4).This spontaneous case, reported by a consumer who contacted the company to report an adverse event, concerned a male patient of unknown age, and origin.Medical history included diabetic since 1993.Concomitant medications were not provided.The patient had no history of pancreatitis.The patient received insulin lispro (rdna origin) injection (humalog) cartridge and human insulin isophane suspension (rdna origin) injection (humulin n) cartridge; both via reusable pens (humapen luxura, burgundy), at an unknown dose and frequency, via an unknown route of administration, for the treatment of diabetes, beginning on an unknown date.On an unknown date in 2010, while on insulin lispro and human insulin isophane suspension therapies, he experienced hyperglycemia with loss of consciousness and mental confusion and was hospitalized.Reportedly, he was using humapen luxura, burgundy over ten years.Information regarding corrective treatment, outcome of the events and status of insulin lispro and human insulin isophane suspension therapies was not provided.The operator of the humapen luxura, burgundy was the patient and his training status was not provided.The general humapen luxura, burgundy duration of use was not provided.The suspect humapen luxura, burgundy duration of use was of over ten years.The action taken with humapen luxura, burgundy was unknown, and its return was not expected.The initial reporting consumer did not provide the relatedness assessment between the events and insulin lispro and human insulin isophane suspension therapies and humapen luxura, burgundy device.This case was cross-referenced with the following cases, (b)(4) and (b)(4) (same patient).Update 20-jul-2023: initial and follow up information received on 14-jul-2023, 17-jul-2023 and 18-jul-2023, were processed together.Update 21jul2023: additional information received on 21jul2023 from the global product complaint database.Entered the device specific safety summary (dsss); updated the medwatch and european and canadian (eu/ca) device fields.Corresponding fields and narrative updated accordingly.
 
Manufacturer Narrative
B.5.Narrative field; new updated and corrected information is referenced within the update statements in b.5.Please refer to statement dated (b)(6) 2023 in the b.5.Field.No further follow up is planned.Evaluation summary: the reporter stated the patient used the humapen luxura burgundy since approximately 2013.There was no product complaint for the device and the device was not returned for investigation.There was evidence of improper use of the device.The patient used the humapen luxura burgundy for approximately ten years.The humapen luxura burgundy user manual states to not use the pen for more than six years after the first use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HUMAPEN LUXURA BURGUNDY
Type of Device
FOR TREATMENT PURPOSES
Manufacturer (Section D)
ELI LILLY AND COMPANY
lilly corporate center
indianapolis IN 46285
Manufacturer (Section G)
PHILLIPS-MEDISIZE CORPORATION
medical device manufacturing
415 red cedar street
menomonie WI 54751
Manufacturer Contact
catherine cassidy
lilly corporate center
indianapolis, IN 46285
3174332191
MDR Report Key17373462
MDR Text Key319557022
Report Number1819470-2023-00050
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K142518
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 07/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model NumberMS9662
Device Lot Number1205B01
Was Device Available for Evaluation? No
Date Manufacturer Received07/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient SexMale
-
-